CLARIANT ADR 1/SF 4 Total Liabilities
CLARIANT ADR 1/SF 4 total liabilities. Based on the latest financial reports, CLARIANT ADR 1/SF 4 (CLRS) has total liabilities worth €3.69 Billion EUR (≈ $4.31 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check CLRS asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of CLARIANT ADR 1/SF 4 (2021–2025)
Total liabilities of CLARIANT ADR 1/SF 4 from 2021 to 2025. This chart illustrates how CLARIANT ADR 1/SF 4's total liabilities have evolved over time, based on quarterly financial data.
CLARIANT ADR 1/SF 4 Competitors by Total Liabilities
The table below lists competitors of CLARIANT ADR 1/SF 4 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AstraZeneca PLC
LSE:AZN
|
UK | GBX65.80 Billion |
|
Cal-Comp Electronics (Thailand) Public Company Limited
TW:9105
|
Taiwan | NT$51.99 Billion |
|
Ansell Limited
F:PD1A
|
Germany | €1.34 Billion |
|
First Bancorp
NASDAQ:FBNC
|
USA | $11.33 Billion |
|
Empresas CMPC
SN:CMPC
|
Chile | CL$10.61 Billion |
|
ZIM Integrated Shipping Services Ltd.
F:2SV
|
Germany | €6.98 Billion |
|
Five9 Inc
NASDAQ:FIVN
|
USA | $1.05 Billion |
|
NBT Bancorp Inc
NASDAQ:NBTB
|
USA | $14.27 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down CLARIANT ADR 1/SF 4's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see CLARIANT ADR 1/SF 4 assets under control.
Liquidity & Leverage Metrics
CLARIANT ADR 1/SF 4 Total Liabilities Ratios Explained
CLARIANT ADR 1/SF 4 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.64 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.82 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CLARIANT ADR 1/SF 4's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CLARIANT ADR 1/SF 4 (2021–2025)
The table below shows the annual total liabilities of CLARIANT ADR 1/SF 4 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €3.69 Billion ≈ $4.31 Billion |
-1.78% |
| 2024-12-31 | €3.76 Billion ≈ $4.39 Billion |
+18.60% |
| 2023-12-31 | €3.17 Billion ≈ $3.70 Billion |
-13.82% |
| 2022-12-31 | €3.67 Billion ≈ $4.30 Billion |
-18.22% |
| 2021-12-31 | €4.49 Billion ≈ $5.25 Billion |
-- |
About CLARIANT ADR 1/SF 4
Clariant AG develops, manufactures, distributes, and sells specialty chemicals in Switzerland, Europe, the Middle East, Africa, the United States, and the Asia Pacific. It operates through Care Chemicals, Catalysts, and Adsorbents & Additives segments. The Care Chemicals segment offers personal and home care, crop solutions, industrial applications, base chemicals, oil services, and mining soluti… Read more